Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial
Ready-to-use therapeutic foods (RUTF) are lipid-based pastes widely used in the treatment of acute malnutrition. Current specifications for RUTF permit a high n-6 polyunsaturated fatty acid (PUFA) content and low n-3 PUFA, with no stipulated requirements for preformed long-chain n-3 PUFA. The object...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2015
|
| _version_ | 1797106030236139520 |
|---|---|
| author | Jones, K Ali, R Khasira, M Odera, D West, A Koster, G Akomo, P Talbert, A Goss, V Ngari, M Thitiri, J Ndoro, S Knight, M Omollo, K Ndungu, A Mulongo, M Bahwere, P Fegan, G Warner, J Postle, A Collins, S Calder, P Berkley, J |
| author_facet | Jones, K Ali, R Khasira, M Odera, D West, A Koster, G Akomo, P Talbert, A Goss, V Ngari, M Thitiri, J Ndoro, S Knight, M Omollo, K Ndungu, A Mulongo, M Bahwere, P Fegan, G Warner, J Postle, A Collins, S Calder, P Berkley, J |
| author_sort | Jones, K |
| collection | OXFORD |
| description | Ready-to-use therapeutic foods (RUTF) are lipid-based pastes widely used in the treatment of acute malnutrition. Current specifications for RUTF permit a high n-6 polyunsaturated fatty acid (PUFA) content and low n-3 PUFA, with no stipulated requirements for preformed long-chain n-3 PUFA. The objective of this study was to develop an RUTF with elevated short-chain n-3 PUFA and measure its impact, with and without fish oil supplementation, on children's PUFA status during treatment of severe acute malnutrition.This randomized controlled trial in children with severe acute malnutrition in rural Kenya included 60 children aged 6 to 50 months who were randomized to receive i) RUTF with standard composition; ii) RUTF with elevated short chain n-3 PUFA; or iii) RUTF with elevated short chain n-3 PUFA plus fish oil capsules. Participants were followed-up for 3 months. The primary outcome was erythrocyte PUFA composition.Erythrocyte docosahexaenoic acid (DHA) content declined from baseline in the two arms not receiving fish oil. Erythrocyte long-chain n-3 PUFA content following treatment was significantly higher for participants in the arm receiving fish oil than for those in the arms receiving RUTF with elevated short chain n-3 PUFA or standard RUTF alone: 3 months after enrollment, DHA content was 6.3% (interquartile range 6.0-7.3), 4.5% (3.9-4.9), and 3.9% (2.4-5.7) of total erythrocyte fatty acids (P <0.001), respectively, while eicosapentaenoic acid (EPA) content was 2.0% (1.5-2.6), 0.7% (0.6-0.8), and 0.4% (0.3-0.5) (P <0.001). RUTF with elevated short chain n-3 PUFA and fish oil capsules were acceptable to participants and carers, and there were no significant differences in safety outcomes.PUFA requirements of children with SAM are not met by current formulations of RUTF, or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA. Clinical and growth implications of revised formulations need to be addressed in large clinical trials.Clinicaltrials.gov NCT01593969. Registered 4 May 2012. |
| first_indexed | 2024-03-07T06:55:53Z |
| format | Journal article |
| id | oxford-uuid:fe207de5-bce5-4a2a-8407-aaaf3792027f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:55:53Z |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:fe207de5-bce5-4a2a-8407-aaaf3792027f2022-03-27T13:34:03ZReady-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trialJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fe207de5-bce5-4a2a-8407-aaaf3792027fEnglishSymplectic Elements at OxfordBioMed Central2015Jones, KAli, RKhasira, MOdera, DWest, AKoster, GAkomo, PTalbert, AGoss, VNgari, MThitiri, JNdoro, SKnight, MOmollo, KNdungu, AMulongo, MBahwere, PFegan, GWarner, JPostle, ACollins, SCalder, PBerkley, JReady-to-use therapeutic foods (RUTF) are lipid-based pastes widely used in the treatment of acute malnutrition. Current specifications for RUTF permit a high n-6 polyunsaturated fatty acid (PUFA) content and low n-3 PUFA, with no stipulated requirements for preformed long-chain n-3 PUFA. The objective of this study was to develop an RUTF with elevated short-chain n-3 PUFA and measure its impact, with and without fish oil supplementation, on children's PUFA status during treatment of severe acute malnutrition.This randomized controlled trial in children with severe acute malnutrition in rural Kenya included 60 children aged 6 to 50 months who were randomized to receive i) RUTF with standard composition; ii) RUTF with elevated short chain n-3 PUFA; or iii) RUTF with elevated short chain n-3 PUFA plus fish oil capsules. Participants were followed-up for 3 months. The primary outcome was erythrocyte PUFA composition.Erythrocyte docosahexaenoic acid (DHA) content declined from baseline in the two arms not receiving fish oil. Erythrocyte long-chain n-3 PUFA content following treatment was significantly higher for participants in the arm receiving fish oil than for those in the arms receiving RUTF with elevated short chain n-3 PUFA or standard RUTF alone: 3 months after enrollment, DHA content was 6.3% (interquartile range 6.0-7.3), 4.5% (3.9-4.9), and 3.9% (2.4-5.7) of total erythrocyte fatty acids (P <0.001), respectively, while eicosapentaenoic acid (EPA) content was 2.0% (1.5-2.6), 0.7% (0.6-0.8), and 0.4% (0.3-0.5) (P <0.001). RUTF with elevated short chain n-3 PUFA and fish oil capsules were acceptable to participants and carers, and there were no significant differences in safety outcomes.PUFA requirements of children with SAM are not met by current formulations of RUTF, or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA. Clinical and growth implications of revised formulations need to be addressed in large clinical trials.Clinicaltrials.gov NCT01593969. Registered 4 May 2012. |
| spellingShingle | Jones, K Ali, R Khasira, M Odera, D West, A Koster, G Akomo, P Talbert, A Goss, V Ngari, M Thitiri, J Ndoro, S Knight, M Omollo, K Ndungu, A Mulongo, M Bahwere, P Fegan, G Warner, J Postle, A Collins, S Calder, P Berkley, J Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial |
| title | Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial |
| title_full | Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial |
| title_fullStr | Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial |
| title_full_unstemmed | Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial |
| title_short | Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial |
| title_sort | ready to use therapeutic food with elevated n 3 polyunsaturated fatty acid content with or without fish oil to treat severe acute malnutrition a randomized controlled trial |
| work_keys_str_mv | AT jonesk readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT alir readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT khasiram readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT oderad readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT westa readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT kosterg readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT akomop readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT talberta readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT gossv readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT ngarim readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT thitirij readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT ndoros readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT knightm readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT omollok readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT ndungua readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT mulongom readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT bahwerep readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT fegang readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT warnerj readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT postlea readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT collinss readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT calderp readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial AT berkleyj readytousetherapeuticfoodwithelevatedn3polyunsaturatedfattyacidcontentwithorwithoutfishoiltotreatsevereacutemalnutritionarandomizedcontrolledtrial |